We are the voice of the home and alternate site infusion
community and the patients we serve
While Congress intended to create a comprehensive Medicare home infusion benefit for Part B DME drugs in the 21st Century Cures Act, flawed implementation by CMS has led to major access issues for Medicare beneficiaries.
Medicare’s coverage of home infusion therapy is limited. Only about 40 drugs therapies are covered under the Part B DMEPOS benefit, leaving the vast majority of home infused-drugs covered by Part D prescription drugs plan.
Home nutrition support keeps people out of the hospital, improves quality of life, and lowers total health care costs—but access is at risk because reimbursement has not kept pace with real-world costs.
NHIA represents and advances the interests of organizations that provide medically necessary infusion therapies and products to patients in alternate sites of care. As part of the association’s efforts to advance the industry, we monitor and advocate on a range of important health care issues. We are focused on clinical and business best-practices that may be subject to legislation, regulation, accreditation, practices of health plans/third party payers, and more. Learn more about the issues impacting home and alternate site infusion and how to use your voice to ensure all patients have access to high quality infusion services so they can lead healthy, independent lives.
The National Home Infusion Association (NHIA) has received clarification from CMS regarding enrollment options for home infusion pharmacies under the current nationwide DMEPOS enrollment moratorium.
The 2026 government funding for Health and Human Services that passed the House of Representatives today includes a change to the qualifying criteria for drugs under Medicare’s home infusion benefit that may expand access to
National Home Infusion Association (NHIA) President and CEO Connie Sullivan testified today before the House Energy and Commerce Committee Subcommittee on Health in support of the Preserving Patient Access to Home Infusion Act (H.R. 2172).
The National Home Infusion Association (NHIA) today announced growing bipartisan momentum for the Preserving Patient Access to Home Infusion Act, with ten new cosponsors signing onto the bill in the wake of NHIA’s Advocacy in
